KR830005187A - 아미노사이클로펜탄 알케노산 및 에스테르의 제조방법 - Google Patents

아미노사이클로펜탄 알케노산 및 에스테르의 제조방법 Download PDF

Info

Publication number
KR830005187A
KR830005187A KR1019810001478A KR810001478A KR830005187A KR 830005187 A KR830005187 A KR 830005187A KR 1019810001478 A KR1019810001478 A KR 1019810001478A KR 810001478 A KR810001478 A KR 810001478A KR 830005187 A KR830005187 A KR 830005187A
Authority
KR
South Korea
Prior art keywords
alkyl
phenyl
optionally substituted
alkoxy
halogen
Prior art date
Application number
KR1019810001478A
Other languages
English (en)
Other versions
KR850000214B1 (ko
Inventor
윌리암 콜링톤 에릭
할레트 페터
죤 윌리스 크리스토퍼
브라드 샤우 죤
프랑크 하이스 노르만
Original Assignee
배리 안소니 뉴샘
글락소 그룹 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 배리 안소니 뉴샘, 글락소 그룹 리미티드 filed Critical 배리 안소니 뉴샘
Publication of KR830005187A publication Critical patent/KR830005187A/ko
Application granted granted Critical
Publication of KR850000214B1 publication Critical patent/KR850000214B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/16—Preparation of halogenated hydrocarbons by replacement by halogens of hydroxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0033—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing sulfur
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/30—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/10—Seven-membered rings having the hetero atoms in positions 1 and 4 not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/112—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/12—Radicals substituted by halogen atoms or nitro or nitroso radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F6/00—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
    • D01F6/58—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products
    • D01F6/62—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products from polyesters
    • D01F6/625—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products from polyesters derived from hydroxy-carboxylic acids, e.g. lactones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Textile Engineering (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Shaping By String And By Release Of Stress In Plastics And The Like (AREA)
  • Artificial Filaments (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

내용 없음

Description

아미노사이클로펜탄 알케노산 및 에스테르의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (1)

  1. 다음 일반식(2)의 화합물을 산화시키거나 R3가 알킬 또는 아르알킬인 화합물을 제조하기 위하여는 R3가 수소원자인 상응하는 화합물을 에스테르화하거나 X가 아세틸렌기인 상응하는 화합물을 환원시키거나 염을 제조하기 위해서는 일반식(Ⅰ)의 화합물을 산(R3가 수소원자임) 또는 염기로 처리하거나 양이온교환에 의해 염을 다른 화합물로 전환시켜서 다음 일반식(1)의 화합물 및 그의 생리학적으로 무독한 염 및 그의 용매화합물을 제조하는 방법.
    상기식에서
    X는 시스 또는 트란스 -CH=CH-이며
    R1은 말단치환체로서 -COOR3(R3는 수소원자 C1-6알킬 또는 C|7-10아르알킬이다)를 가지는 직쇄 또는 측쇄 C1-7알킬이며
    Y는 5내지 8원환의 포화된 복소환 아미노기이며
    (a) 임의로 환중에 -O-, -S-, -SO2-, -NR4(R4는 수소, C1-7알킬 또는 C1-4알킬부위를 가지는 아르알킬이다)를 함유하며/또는
    (b) 하나 또는 2이상의 C1-4알킬기로 임의로 치환된다. R2는 (i) C2-4알카노일
    (ii) 페닐(페닐은 C1-4알킬, C1-4알콕시, 할로겐, C5-7사이클로알킬 또는 페닐 C1-4알킬로 임의로 치환된다), 페닐(C1-4알킬, C1-4알콕시 또는 할로겐으로 임의로 치환된다), 또는 나프틸에 의해 임의로 치환된 C3-6알케닐,
    (iii) C1-12알킬,
    (iv) (a) 페닐[할로겐, 하이드록시, C1-6알킬, C1-6알콕시, C1-4하이드록시알콕시, 트리플루오로메틸, 시아노, 아릴옥시(예 : 페녹시), C5-7사이클로알킬, 아르알콕시(예 : 벤질옥시), 디메틸아미노메틸, 카복스아미도(-CONH2)5, 티오카복스아미도(-CSNH2) C1-4알카노일, -NR5R6(이때 R5는 및 R6는 같거나 다르며 각각은 수소 또는 C1-4알킬이거나 -NR5R6가 위에서 Y에 대해 정의한 바와 같은 포화된 복소환 아미노기이다), C1-3알킬티오, C1-3알킬설피닐, C1-3알킬부를 가지는 페닐알킬, 아미노설포닐, C1-3알카노일아미노설포닐, 페닐설포닐, 페닐설포닐(페닐부는 C1-3알킬 또는 C1-3알콕시에 의해 임의로 치환된다), 니트로 또는 티에닐에 의해 임의로 치환됨).
    (b) 티에닐 또는 푸라닐[티에닐 및 푸라닐기는 C1-6알킬, C1-6알콕시, 아릴(예 : 페닐) 또는 페닐(C1-3)알킬 또는 페닐(C1-3)알콕시(아릴 또는 페닐기는 각 경우 C1-3알킬, C1-3알콕시 또는 할로겐으로 임의 치환된다) 아릴옥시(예 : 펜옥시), C5-7사이클로알킬, 할로겐, 니트로 또는 티에닐에 의해 임의로 치환된다]
    (c) 비페닐(페닐 또는 하나 또는 두개의 C1-4알킬알콕시 또는 할로겐 치환체에 의해 임의로 치환된다) 또는 (d) 나프틸(C1-4알킬, C1-4알콕시 또는 할로겐에 의해 임의로 치환된다)에 의해 치환된 C1-5알킬이며 R10는 -COOR3로 치환된 직쇄 또는 측쇄알킬기, -CH2OH 또는 -CHO이다.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019810001478A 1980-04-30 1981-04-29 아미노사이클로펜탄 알케노산 및 에스테르의 제조방법 KR850000214B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8014256 1980-04-30
GB8014256 1980-04-30
GB8100326 1981-01-07
GB8100326 1981-01-07

Publications (2)

Publication Number Publication Date
KR830005187A true KR830005187A (ko) 1983-08-03
KR850000214B1 KR850000214B1 (ko) 1985-03-06

Family

ID=26275368

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019810001478A KR850000214B1 (ko) 1980-04-30 1981-04-29 아미노사이클로펜탄 알케노산 및 에스테르의 제조방법

Country Status (21)

Country Link
US (2) US4342756A (ko)
JP (2) JPS5718671A (ko)
KR (1) KR850000214B1 (ko)
AT (1) ATA191781A (ko)
AU (1) AU540147B2 (ko)
BE (1) BE888645A (ko)
CH (1) CH646965A5 (ko)
DE (1) DE3117087A1 (ko)
DK (1) DK189881A (ko)
ES (2) ES8207498A1 (ko)
FI (1) FI78293C (ko)
FR (1) FR2481703B1 (ko)
GB (1) GB2075503B (ko)
IE (1) IE51241B1 (ko)
IL (1) IL62734A (ko)
IT (1) IT1170929B (ko)
NL (1) NL8102116A (ko)
NO (1) NO811470L (ko)
NZ (1) NZ196966A (ko)
PT (1) PT72951B (ko)
SE (1) SE8102731L (ko)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7906017L (sv) * 1978-07-11 1980-02-13 Glaxo Group Ltd Prostanoida foreningar
US4438111A (en) 1980-01-09 1984-03-20 Glaxo Group Limited Prostanoid compounds and pharmaceutical formulations
ZA81114B (en) 1980-01-09 1982-01-27 Glaxo Group Ltd Prostanoid compounds and their preparation and pharmaceutical formalation
CA1191134A (en) * 1981-04-29 1985-07-30 Eric W. Collington Aminocyclopentanol acids and esters and their preparation and pharmaceutical formulation
US4410521A (en) * 1981-09-16 1983-10-18 Glaxo Group Limited Aminocyclopentane esters and pharmaceutical formulations
ES515761A0 (es) * 1981-09-16 1983-10-01 Glaxo Group Ltd "un procedimiento para la preparacion de esteres de aminociclopentano".
GR77727B (ko) * 1981-10-29 1984-09-25 Glaxo Group Ltd
IL67041A (en) * 1981-10-29 1988-03-31 Glaxo Group Ltd 2-aminocyclopentane alkanoic and alkenoic acid esters,process for their preparation and pharmaceutical compositions containing them
US4837234A (en) * 1981-12-23 1989-06-06 National Research Development Corporation Prostaglandins
AU561739B2 (en) * 1981-12-23 1987-05-14 British Technology Group Limited Prostaglandins
GB2127406B (en) * 1982-09-16 1986-03-05 Glaxo Group Ltd Piperidinlycyclopentanolheptenoic acid salt
AU576476B2 (en) * 1982-09-16 1988-09-01 Glaxo Group Limited Piperidinylcyclopentanol heptenoic acid salt
IT1170545B (it) * 1982-10-28 1987-06-03 Glaxo Group Ltd Procedimento per la produzione di acidi amminociclopentanoici
GB8307099D0 (en) * 1983-03-15 1983-04-20 Glaxo Group Ltd Carbocyclic compounds
IL72862A (en) * 1983-09-06 1988-07-31 Glaxo Group Ltd Aminocyclopentane alkenoic acids and esters,process for their preparation and pharmaceutical compositions containing them
GB2167404A (en) * 1984-10-26 1986-05-29 Glaxo Group Ltd Prostanoid aminocyclopentane alkenoic acids and esters, their preparation and pharmaceutical formulation
GB8601985D0 (en) * 1986-01-28 1986-03-05 Glaxo Group Ltd Chemical process
GB8625326D0 (en) * 1986-10-22 1986-11-26 Glaxo Group Ltd Medicaments
GB8715333D0 (en) * 1987-06-30 1987-08-05 Glaxo Group Ltd Process
GB9720270D0 (en) * 1997-09-25 1997-11-26 Pharmagene Lab Limited Medicaments for the treatment of migraine
GB2330307A (en) * 1998-02-07 1999-04-21 Glaxo Group Ltd EP4 Receptor antagonists as bone resorption inhibitors
US6414006B1 (en) 1998-10-15 2002-07-02 Merck Frosst Canada & Co. Methods for inhibiting bone resorption
DE60012751T2 (de) * 1999-08-10 2005-01-20 Glaxo Group Ltd., Greenford Verwendung von EP 4 Rezeptorliganden zur Behandlung von neuropathischem Schmerz
GB0124124D0 (en) * 2001-10-08 2001-11-28 Medical Res Council Methods of treatment
GB0208785D0 (en) * 2002-04-17 2002-05-29 Medical Res Council Treatment methtods
JP2005532295A (ja) * 2002-04-17 2005-10-27 メディカル リサーチ カウンシル 月経過多を治療するためのＦＰレセプターアンタゴニスト又はＰＧＦ２αアンタゴニスト
JP2006517576A (ja) * 2003-02-14 2006-07-27 メディカル リサーチ カウンシル 病理的子宮症状の治療のためのｉｐレセプターアンタゴニスト
CA2618089A1 (en) 2005-08-08 2007-02-15 Argenta Discovery Ltd. Bicyclo[2.2.]hept-7-ylamine derivatives and their uses
JP2008193940A (ja) * 2007-02-13 2008-08-28 Honda Motor Co Ltd ポリヒドロキシ酪酸精製方法
WO2014120907A1 (en) 2013-01-30 2014-08-07 Ecolab Usa Inc. Hydrogen sulfide scavengers
CN107438601B (zh) 2015-04-22 2020-11-13 艺康美国股份有限公司 开发用于去除硫化氢的高温稳定清除剂
EP3347441B1 (en) 2015-09-08 2020-06-10 Ecolab USA Inc. Hydrocarbon soluble/dispersible hemiformals as hydrogen sulfide scavengers
CA2997416C (en) 2015-09-08 2023-06-27 Ecolab Usa Inc. Hydrogen sulfide scavengers
MX2019001208A (es) 2016-07-29 2019-05-02 Ecolab Usa Inc Composiciones antiincrustantes y barredoras de sulfuro de hidrogeno.
US10538710B2 (en) 2017-07-13 2020-01-21 Ecolab Usa Inc. Hydrogen sulfide scavengers
BR112021014463A2 (pt) 2019-01-23 2021-09-21 Championx Usa Inc Remoção completa de sólidos durante operações sequestrantes de sulfeto de hidrogênio que usam um sequestrante e um aceitador de michael

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1553293A (en) * 1976-02-23 1979-09-26 Lepetit Spa Azaprostaglandins
US4189606A (en) * 1976-02-23 1980-02-19 Gruppo Lepetit S.P.A. 13-Azaprostaglandins
GB2028805B (en) * 1978-07-11 1982-11-03 Glaxo Group Ltd Prostanoid compounds
SE7906017L (sv) * 1978-07-11 1980-02-13 Glaxo Group Ltd Prostanoida foreningar
US4239778A (en) * 1978-09-12 1980-12-16 The University Of Illinois Foundation Azaprostanoic acid analogs and their use as inhibitors of platelet aggregation

Also Published As

Publication number Publication date
PT72951A (en) 1981-05-01
ATA191781A (de) 1985-11-15
DE3117087A1 (de) 1982-03-11
IL62734A0 (en) 1981-06-29
IE810957L (en) 1981-10-30
NZ196966A (en) 1984-05-31
NL8102116A (nl) 1981-11-16
SE8102731L (sv) 1981-12-21
DK189881A (da) 1981-10-31
JPH0314028B2 (ko) 1991-02-25
KR850000214B1 (ko) 1985-03-06
GB2075503A (en) 1981-11-18
FI78293B (fi) 1989-03-31
FR2481703B1 (fr) 1985-08-02
IL62734A (en) 1985-10-31
CH646965A5 (en) 1984-12-28
ES501740A0 (es) 1982-09-16
FI811350L (fi) 1981-10-31
FR2481703A1 (fr) 1981-11-06
JPS5882723A (ja) 1983-05-18
AU540147B2 (en) 1984-11-01
ES8303386A1 (es) 1983-02-01
ES8207498A1 (es) 1982-09-16
GB2075503B (en) 1984-03-28
IT1170929B (it) 1987-06-03
JPS5718671A (en) 1982-01-30
PT72951B (en) 1983-06-15
JPH0263054B2 (ko) 1990-12-27
IE51241B1 (en) 1986-11-12
US4327092A (en) 1982-04-27
AU6995781A (en) 1981-11-05
ES510838A0 (es) 1983-02-01
NO811470L (no) 1981-11-02
US4342756A (en) 1982-08-03
BE888645A (fr) 1981-10-30
IT8148367A0 (it) 1981-04-29
FI78293C (fi) 1989-07-10

Similar Documents

Publication Publication Date Title
KR830005187A (ko) 아미노사이클로펜탄 알케노산 및 에스테르의 제조방법
ES2059069T3 (es) Nuevos derivados de 1-alcoxi-(2-acilamino-etil)-naftalenos y su procedimiento de preparacion.
FR2446834A1 (fr) Octahydro-pyrazolo(3,4-g)quinoleines utiles comme intermediaires de synthese
DE3665711D1 (de) Novel guanidinomethylbenzoic acid derivatives
KR900018113A (ko) 티에노-트리아졸로-디아제핀 유도체, 그의 제조 방법 및 그를 함유하는 치료 조성물
KR850004574A (ko) 나프탈렌 유도체의 제조방법
FR2376143A1 (fr) Bis (amino-4' phenyl)-2,5 oxadiazoles-1,3,4, procede de preparation et utilisation comme composantes bis-diazoiques
KR850000389A (ko) 아미노페닐 에틸아민 유도체의 제조방법
SE7909751L (sv) 4,1-bensoxazepiner och tia-analoger derav
FR2357558A1 (fr) 2,6-methano-2h-1-benzoxocines
ES2038794T3 (es) Procedimiento para la obtencion de derivados del azolil-propenil- y azolilmetiloxirano y fungicidas que les contienen.
FR2398736A1 (fr) Derives a-halogenomethyles d'aminoacides, leur procede de preparation et leur utilisation comme antiallergiques
SE8005687L (sv) Nya 10-halogen-e-homoeburnaner jemte sett for deras framstellning
SE7711146L (sv) Tiaprostaglandiner
KR850003382A (ko) 디아릴인단-1,3-디온의 제조방법
KR840004720A (ko) 살충제 조성물 및 이의 제조방법
FR2428039A1 (fr) Nouveaux derives d'acide (1,3-dihydrobenzo(c)thienyl)acetique
DK152088D0 (da) Fremgangsmaade til fremstilling af diphenylacetylener
ES547691A0 (es) Procedimiento para preparar compuestos intermedios para ob- tener derivados de los acidos 16-fenoxi y 16-fenoxi susti- tuido-prostatrienoicos
SE8402361L (sv) Nya acylaminofenolderivat
KR890002015A (ko) 2-니트로-5-(치환된 피리딜옥시)벤조히드록 심산 유도체
KR840001969A (ko) 아미노사이클로펜탄알케노산의 제조방법
SE8100122L (sv) Nya 2-aminometyl-6-halo-fenoler, framstellning derav och farmaceutiska kompositioner innehallande dessa
JPS5430138A (en) Cyclopropane carboxylate and its preparation
JPS5416466A (en) Novel 3-hydroxypyrrolldine-3-carboxylic derivative

Legal Events

Date Code Title Description
E701 Decision to grant or registration of patent right